The U.S. Biomedical Refrigerators And Freezers Market was valued at USD 1.4 billion in 2024 and is estimated to grow at a CAGR of 5.1% to reach USD 2.4 billion by 2034.
This steady expansion is driven by several factors, including growing federal support for research and clinical trials, advancements in biomedical refrigeration technology, the increasing geriatric population, and the rapid development of biopharmaceuticals. Continuous funding from federal agencies such as the National Institutes of Health (NIH) plays a pivotal role, as billions are allocated annually to support life sciences research, including clinical trials that require precise cold storage for biological samples, vaccines, and investigational drugs. This financial backing not only stimulates innovation but also escalates demand for advanced refrigeration systems that safeguard temperature-sensitive materials. Additionally, the aging population in the U.S. contributes significantly to market growth, as older adults are more susceptible to chronic conditions such as cancer, diabetes, and cardiovascular diseases, which often necessitate treatments requiring secure and reliable cold storage solutions.
The blood bank refrigerators segment was valued at USD 217.8 million in 2024 and is expected to grow to USD 372.2 million by 2034, achieving a CAGR of 5.6%. These refrigeration units are specifically designed to store temperature-sensitive biological materials, reagents, and chemicals, maintaining exact temperature control essential for preserving sample integrity and supporting accurate laboratory operations.
The diagnostic centers segment held a 36.8% share in 2024. Diagnostic centers rely on biomedical refrigerators and freezers to preserve biological samples such as blood, urine, and tissue specimens under precise conditions, reducing the risk of degradation and ensuring reliable test outcomes.
Key companies operating in the U.S. Biomedical Refrigerators and Freezers Market include Stirling Ultracold, NuAire, Helmer Scientific, Thermo Fisher Scientific, Arctiko, So-Low Environmental Equipment, PHC Corporation, Aegis Scientific, Follett Products, Cardinal Health, B Medical Systems, Migali Scientific, Eppendorf, Azbil Corporation, and Haier Biomedical. Market leaders strengthen their presence by investing in R&D to develop innovative refrigeration technologies with precise temperature control, energy efficiency, and digital monitoring capabilities. Companies focus on expanding product portfolios, introducing modular and ultra-low temperature units, and enhancing software integration for remote monitoring. Strategic partnerships with research institutions, hospitals, and biopharma companies help extend reach and foster trust. Additionally, firms leverage service networks for maintenance, calibration, and retrofitting solutions to enhance customer satisfaction and loyalty, while complying with evolving regulatory standards.
This product will be delivered within 2-4 business days.
This steady expansion is driven by several factors, including growing federal support for research and clinical trials, advancements in biomedical refrigeration technology, the increasing geriatric population, and the rapid development of biopharmaceuticals. Continuous funding from federal agencies such as the National Institutes of Health (NIH) plays a pivotal role, as billions are allocated annually to support life sciences research, including clinical trials that require precise cold storage for biological samples, vaccines, and investigational drugs. This financial backing not only stimulates innovation but also escalates demand for advanced refrigeration systems that safeguard temperature-sensitive materials. Additionally, the aging population in the U.S. contributes significantly to market growth, as older adults are more susceptible to chronic conditions such as cancer, diabetes, and cardiovascular diseases, which often necessitate treatments requiring secure and reliable cold storage solutions.
The blood bank refrigerators segment was valued at USD 217.8 million in 2024 and is expected to grow to USD 372.2 million by 2034, achieving a CAGR of 5.6%. These refrigeration units are specifically designed to store temperature-sensitive biological materials, reagents, and chemicals, maintaining exact temperature control essential for preserving sample integrity and supporting accurate laboratory operations.
The diagnostic centers segment held a 36.8% share in 2024. Diagnostic centers rely on biomedical refrigerators and freezers to preserve biological samples such as blood, urine, and tissue specimens under precise conditions, reducing the risk of degradation and ensuring reliable test outcomes.
Key companies operating in the U.S. Biomedical Refrigerators and Freezers Market include Stirling Ultracold, NuAire, Helmer Scientific, Thermo Fisher Scientific, Arctiko, So-Low Environmental Equipment, PHC Corporation, Aegis Scientific, Follett Products, Cardinal Health, B Medical Systems, Migali Scientific, Eppendorf, Azbil Corporation, and Haier Biomedical. Market leaders strengthen their presence by investing in R&D to develop innovative refrigeration technologies with precise temperature control, energy efficiency, and digital monitoring capabilities. Companies focus on expanding product portfolios, introducing modular and ultra-low temperature units, and enhancing software integration for remote monitoring. Strategic partnerships with research institutions, hospitals, and biopharma companies help extend reach and foster trust. Additionally, firms leverage service networks for maintenance, calibration, and retrofitting solutions to enhance customer satisfaction and loyalty, while complying with evolving regulatory standards.
Comprehensive Market Analysis and Forecast
- Industry trends, key growth drivers, challenges, future opportunities, and regulatory landscape
- Competitive landscape with Porter’s Five Forces and PESTEL analysis
- Market size, segmentation, and regional forecasts
- In-depth company profiles, business strategies, financial insights, and SWOT analysis
This product will be delivered within 2-4 business days.
Table of Contents
Chapter 1 Methodology and Scope
Chapter 2 Executive Summary
Chapter 3 Industry Insights
Chapter 4 Competitive Landscape, 2024
Chapter 5 Market Estimates and Forecast, by Product, 2021-2034 ($ Mn)
Chapter 6 Market Estimates and Forecast, by End Use, 2021-2034 ($ Mn)
Chapter 7 Company Profiles
Companies Mentioned
The companies profiled in this U.S. Biomedical Refrigerators and Freezers market report include:- Aegis Scientific
- Azbil Corporation
- Arctiko
- B Medical Systems
- Cardinal Health
- Eppendorf
- Follett Products
- Helmer Scientific
- Haier Biomedical
- Migali Scientific
- NuAire
- PHC Corporation
- So-Low Environmental Equipment
- Stirling Ultracold
- Thermo Fisher Scientific
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 60 |
| Published | December 2025 |
| Forecast Period | 2024 - 2034 |
| Estimated Market Value ( USD | $ 1.4 Billion |
| Forecasted Market Value ( USD | $ 2.4 Billion |
| Compound Annual Growth Rate | 5.1% |
| Regions Covered | United States |
| No. of Companies Mentioned | 16 |
